Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.24 USD | +0.41% | -3.31% | +31.30% |
Financials (USD)
Sales 2024 * | 64.29M | Sales 2025 * | 115M | Capitalization | 1.64B |
---|---|---|---|---|---|
Net income 2024 * | -317M | Net income 2025 * | -360M | EV / Sales 2024 * | 24.4 x |
Net cash position 2024 * | 68.82M | Net Debt 2025 * | 36.47M | EV / Sales 2025 * | 14.6 x |
P/E ratio 2024 * |
-5.33
x | P/E ratio 2025 * |
-4.96
x | Employees | 385 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.35% |
Latest transcript on Agios Pharmaceuticals, Inc.
1 day | +0.41% | ||
1 week | -3.31% | ||
Current month | -9.53% | ||
1 month | -13.16% | ||
3 months | +28.30% | ||
6 months | +18.05% | ||
Current year | +31.30% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Goff
CEO | Chief Executive Officer | 55 | 22-08-07 |
Cecilia Jones
DFI | Director of Finance/CFO | 49 | 22-09-25 |
Jacqualyn Fouse
CHM | Chairman | 62 | 17-12-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Capello
BRD | Director/Board Member | 69 | 23-05-31 |
Director/Board Member | 64 | 14-12-08 | |
May Kin Ho
BRD | Director/Board Member | 71 | 15-06-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.52% | 1 M€ | -.--% | - | |
0.16% | 0 M€ | 0.00% | - | |
0.14% | 0 M€ | 0.00% | - | |
0.06% | 464 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 29.24 | +0.41% | 434,786 |
24-03-27 | 29.12 | +0.21% | 666,420 |
24-03-26 | 29.06 | -2.09% | 554,730 |
24-03-25 | 29.68 | -0.67% | 413,837 |
24-03-22 | 29.88 | -1.19% | 442,221 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.30% | 1.64B | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |